Skip to content

Nattokinase trial found no clear improvement in overall cognition

An exploratory visuospatial result favored the supplement, but the main global cognition result did not show a statistically significant difference from placebo.

By 100HP editorialAbstract-based explanation checked

Based on the published abstract. The full paper may contain additional methods, results and limitations.

The 30-second takeaway

Nattokinase did not produce a statistically significant improvement in global cognition compared with placebo in this trial of people with symptom-free arterial narrowing. An exploratory analysis suggested a benefit in visuospatial function, a narrower cognitive domain. That signal should be read alongside the main null result, rather than as evidence of broad cognitive enhancement.

Keep in mind

Only 88 participants completed follow-up while taking the assigned treatment as required. The visuospatial finding was exploratory, and the abstract does not establish its clinical importance or whether any benefit persists beyond the study.

THE NUMBERS, WITH CONTEXT

What researchers found

Mean difference: 0.038

Change in Montreal Cognitive Assessment score

Nattokinase versus placebo after 6 months, per-protocol analysis; 95% CI: -1.109 to 1.163; P = 0.948.

J Stroke Cerebrovasc Dis, 2026 · Original source ↓

What the trial tested

Participants were randomly assigned to supplement or placebo, with cognitive testing and brain imaging before and after treatment. The main reported global cognition comparison concerned score changes on the Montreal Cognitive Assessment.

Reading the mixed results

The global cognition confidence interval included differences in either direction. A separate visuospatial result favored nattokinase, and the authors report consistent intention-to-treat findings. These results leave broad cognitive benefit unproven while identifying a narrower question for further study.

CHECK THE ORIGINAL

The original publication

Nattokinase supplementation for cognitive enhancement in asymptomatic intracranial/carotid stenosis: A randomized controlled trial.

Zhang K, Zhang X, Wang A et al.
J Stroke Cerebrovasc Dis · 2026

PubMed ID
41325794
Record checked

AI-assisted research and writing. This explains one selected publication; it is not a complete review of everything known. Our approach.